It was reported that in-stent stenosis of mid and distal superficial femoral artery (sfa) occurred requiring additional intervention.The patient was enrolled in the eminent clinical study with the patient identifier of (b)(6).The patient underwent treatment with the eluvia stent on (b)(6) 2017 as part of the eminent clinical trial.The target lesion, located in the mid and distal sfa of the left leg, had a 5mm reference vessel diameter proximal and distal respectively, and a total length of 80mm visually estimated.The target lesion was 90% occluded and crossed through true lumen.Pre-dilatation was performed using one unspecified balloon.Afterwards an eluvia stent (6x100mm) was implanted.Post-dilatation was performed using one unspecified balloon, and 0% residual stenosis remained.On (b)(6) 2019 a re-occlusion of the target lesion left leg was observed.The patient was hospitalized on (b)(6) 2019, and an interventional procedure was performed (lysis and percutaneous transluminal angioplasty).The patient was discharged on (b)(6) 2019.The event was assessed by the investigator as serious and reported as resolved as of (b)(6) 2019.
|